News

Change to the Board of Directors (Chair)

Abingdon, UK, 25th April 2012, OBS Medical Ltd, a world leader in innovative software solutions for the improvement of patients’ lives in the hospital, at home, and through industry with advanced clinical solutions for new drug development, is pleased to announce the following change to the Board of Directors.

Read more >

Changes to the Board of Directors

Abingdon, UK, 17th April 2012, OBS Medical Ltd, a world leader in innovative software solutions for the improvement of patients’ lives in the hospital, at home, and through industry with advanced clinical solutions for new drug development, is pleased to announce the following changes to the Board of Directors.

Read more >

Visensia 3.3 Released

OBS Medical are pleased to announce the release of Visensia 3.3.  This is a new release with some enhancements. Users of previous releases are encouraged to upgrade.  Please “read more” for the full details of the release.

Read more >

Top 5 CRO evaluates BioQT

A top 5 global Clinical Research Organisation has requested the opportunity to evaluate BioQT with the view to use for automated QT analysis requirements. This is based on a growing demand from the pharmaceutical industry that is recognising the benefits which can be gained from this technology.

Read more >

Changes to the Board of Directors

OBS Medical Ltd, the patient monitoring systems company, is pleased to announce the following changes to the Board of Directors.

Richard Moon, Chairman and Non-Executive Director and Allan Cockell, Non-Executive Director, are retiring from Board with immediate effect.

Read more >

OBS Medical Ltd Announces 510k Clearance for Visensia

OBS Medical Ltd, today announced that Visensia has received 510k clearance from the FDA. This is the fourth 510k clearance for Visensia since the original introduction of Visensia (Originally known as BioSignTM) in 2005. Visensia was the first FDA cleared patient health index device with alerts on the market and is continuing to develop innovative leading edge products.

Read more >

Help4Mood Project

OBS Medical and t+ Medical Ltd presents the project Help4Mood, a significant advance in supporting the recovery of people with major depression at home. The project is funded by the European Union’s Seventh Framework Programme, has a budget of around 3 million euros.

Read more >

Page 1 of 5 pages  1 2 3 >  Last ›